Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 417

1.

Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists.

Williamson SR, Rao P, Hes O, Epstein JI, Smith SC, Picken MM, Zhou M, Tretiakova MS, Tickoo SK, Chen YB, Reuter VE, Fleming S, Maclean FM, Gupta NS, Kuroda N, Delahunt B, Mehra R, Przybycin CG, Cheng L, Eble JN, Grignon DJ, Moch H, Lopez JI, Kunju LP, Tamboli P, Srigley JR, Amin MB, Martignoni G, Hirsch MS, Bonsib SM, Trpkov K.

Am J Surg Pathol. 2018 Jun 6. doi: 10.1097/PAS.0000000000001087. [Epub ahead of print]

PMID:
29878933
2.

Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC).

Ditzel HM, Strickland KC, Meserve EE, Stover E, Konstantinopoulos PA, Matulonis UA, Muto MG, Liu JF, Feltmate C, Horowitz N, Berkowitz RS, Gupta M, Hecht JL, Lin DI, Jochumsen KM, Welch WR, Hirsch MS, Quade BJ, Lee KR, Crum CP, Mutter GL, Nucci MR, Howitt BE.

Int J Gynecol Pathol. 2018 May 10. doi: 10.1097/PGP.0000000000000513. [Epub ahead of print]

PMID:
29750700
3.

Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.

Ohe C, Smith SC, Sirohi D, Divatia M, de Peralta-Venturina M, Paner GP, Agaimy A, Amin MB, Argani P, Chen YB, Cheng L, Colecchia M, Compérat E, Werneck da Cunha I, Epstein JI, Gill AJ, Hes O, Hirsch MS, Jochum W, Kunju LP, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Nesi G, Osunkoya AO, Picken MM, Rao P, Reuter VE, de Oliveira Salles PG, Schultz L, Tickoo SK, Tomlins SA, Trpkov K, Amin MB.

Am J Surg Pathol. 2018 Mar;42(3):279-292. doi: 10.1097/PAS.0000000000001000.

PMID:
29309300
4.

Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer.

Tucker DW, Getchell CR, McCarthy ET, Ohman AW, Sasamoto N, Xu S, Ko JY, Gupta M, Shafrir A, Medina JE, Lee JJ, MacDonald LA, Malik A, Hasselblatt KT, Li W, Zhang H, Kaplan SJ, Murphy GF, Hirsch MS, Liu JF, Matulonis UA, Terry KL, Lian CG, Dinulescu DM.

Clin Cancer Res. 2018 Mar 15;24(6):1389-1401. doi: 10.1158/1078-0432.CCR-17-1958. Epub 2017 Dec 20.

5.

Clear cell tubopapillary renal cell carcinoma mimicking polycystic kidney disease: A case report.

Gomez G, Althaus A, Gruessner CE, Hirsch MS, Steele GS.

Urol Case Rep. 2017 Oct 15;16:35-37. doi: 10.1016/j.eucr.2017.10.003. eCollection 2018 Jan.

6.

High grade serous ovarian carcinomas originate in the fallopian tube.

Labidi-Galy SI, Papp E, Hallberg D, Niknafs N, Adleff V, Noe M, Bhattacharya R, Novak M, Jones S, Phallen J, Hruban CA, Hirsch MS, Lin DI, Schwartz L, Maire CL, Tille JC, Bowden M, Ayhan A, Wood LD, Scharpf RB, Kurman R, Wang TL, Shih IM, Karchin R, Drapkin R, Velculescu VE.

Nat Commun. 2017 Oct 23;8(1):1093. doi: 10.1038/s41467-017-00962-1.

7.

PNL2: an adjunctive biomarker for renal angiomyolipomas and perivascular epithelioid cell tumours.

Gulavita P, Fletcher CDM, Hirsch MS.

Histopathology. 2018 Feb;72(3):441-448. doi: 10.1111/his.13369. Epub 2017 Nov 21.

PMID:
28837273
8.

Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma.

Sirohi D, Smith SC, Ohe C, Colombo P, Divatia M, Dragoescu E, Rao P, Hirsch MS, Chen YB, Mehra R, Amin MB.

Hum Pathol. 2017 Sep;67:134-145. doi: 10.1016/j.humpath.2017.07.006. Epub 2017 Jul 15.

PMID:
28716439
9.

De Novo Tumors of Teratoma: Ganglioneuroma Arising From a Mature Cystic Teratoma of the Ovary.

Coy S, Meserve E, Berkowitz R, Hirsch MS.

Int J Gynecol Pathol. 2018 May;37(3):296-300. doi: 10.1097/PGP.0000000000000409.

PMID:
28700440
10.

PRKCI promotes immune suppression in ovarian cancer.

Sarkar S, Bristow CA, Dey P, Rai K, Perets R, Ramirez-Cardenas A, Malasi S, Huang-Hobbs E, Haemmerle M, Wu SY, McGuire M, Protopopov A, Jiang S, Liu JF, Hirsch MS, Chang Q, Lazar AJ, Sood AK, Drapkin R, DePinho R, Draetta G, Chin L.

Genes Dev. 2017 Jun 1;31(11):1109-1121. doi: 10.1101/gad.296640.117. Epub 2017 Jul 11.

11.

PAX8 Distinguishes Diffuse Large B-Cell Lymphoma Mimicking Sarcoma.

Hirsch MS, Nascimento AF.

Case Rep Pathol. 2017;2017:6714549. doi: 10.1155/2017/6714549. Epub 2017 May 28.

12.

Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists.

Williamson SR, Gadde R, Trpkov K, Hirsch MS, Srigley JR, Reuter VE, Cheng L, Kunju LP, Barod R, Rogers CG, Delahunt B, Hes O, Eble JN, Zhou M, McKenney JK, Martignoni G, Fleming S, Grignon DJ, Moch H, Gupta NS.

Hum Pathol. 2017 May;63:149-156. doi: 10.1016/j.humpath.2017.03.004. Epub 2017 Mar 14.

PMID:
28315424
13.

Genomic evolution and chemoresistance in germ-cell tumours.

Taylor-Weiner A, Zack T, O'Donnell E, Guerriero JL, Bernard B, Reddy A, Han GC, AlDubayan S, Amin-Mansour A, Schumacher SE, Litchfield K, Turnbull C, Gabriel S, Beroukhim R, Getz G, Carter SL, Hirsch MS, Letai A, Sweeney C, Van Allen EM.

Nature. 2016 Nov 30;540(7631):114-118. doi: 10.1038/nature20596.

14.

SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance.

Sheets JN, Iwanicki M, Liu JF, Howitt BE, Hirsch MS, Gubbels JA, Drapkin R, Egland KA.

Oncogenesis. 2016 Oct 24;5(10):e264. doi: 10.1038/oncsis.2016.64.

15.

Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology.

Glazer DI, Hassanzadeh E, Fedorov A, Olubiyi OI, Goldberger SS, Penzkofer T, Flood TA, Masry P, Mulkern RV, Hirsch MS, Tempany CM, Fennessy FM.

Abdom Radiol (NY). 2017 Mar;42(3):918-925. doi: 10.1007/s00261-016-0942-1.

16.

Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes.

Mnatzakanian GN, Shinagare AB, Sahni VA, Hirsch MS, Silverman SG.

Abdom Radiol (NY). 2016 Nov;41(11):2187-2195.

PMID:
27383741
17.

Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment.

Wang S, Blois A, El Rayes T, Liu JF, Hirsch MS, Gravdal K, Palakurthi S, Bielenberg DR, Akslen LA, Drapkin R, Mittal V, Watnick RS.

Sci Transl Med. 2016 Mar 9;8(329):329ra34. doi: 10.1126/scitranslmed.aad5653.

PMID:
26962158
18.

Preface.

Hirsch MS.

Surg Pathol Clin. 2015 Dec;8(4):xi. doi: 10.1016/j.path.2015.10.005. No abstract available.

PMID:
26612227
19.

Adult Renal Cell Carcinoma: A Review of Established Entities from Morphology to Molecular Genetics.

Hirsch MS, Signoretti S, Dal Cin P.

Surg Pathol Clin. 2015 Dec;8(4):587-621. doi: 10.1016/j.path.2015.09.003. Review.

PMID:
26612217
20.

Infectious Diseases Society of America and Gain-of-Function Experiments With Pathogens Having Pandemic Potential.

Frank GM, Adalja A, Barbour A, Casadevall A, Dormitzer PR, Duchin J, Hayden FG, Hirsch MS, Hynes NA, Lipsitch M, Pavia AT, Relman DA.

J Infect Dis. 2016 May 1;213(9):1359-61. doi: 10.1093/infdis/jiv474. Epub 2015 Sep 27. No abstract available.

PMID:
26416656
21.

Non-clear cell renal cell carcinoma, part 2: therapy.

Valenca LB, Hirsch MS, Choueiri TK, Harshman LC.

Clin Adv Hematol Oncol. 2015 Jun;13(6):383-91. Review.

PMID:
26352894
22.

Non-clear cell renal cell carcinoma, part 1: histology.

Valenca LB, Hirsch MS, Choueiri TK, Harshman LC.

Clin Adv Hematol Oncol. 2015 May;13(5):308-13. Review.

PMID:
26352775
23.

Testosterone and "Age-Related Hypogonadism"--FDA Concerns.

Nguyen CP, Hirsch MS, Moeny D, Kaul S, Mohamoud M, Joffe HV.

N Engl J Med. 2015 Aug 20;373(8):689-91. doi: 10.1056/NEJMp1506632. No abstract available.

PMID:
26287846
24.

Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma.

Novak M, Lester J, Karst AM, Parkash V, Hirsch MS, Crum CP, Karlan BY, Drapkin R.

Gynecol Oncol. 2015 Oct;139(1):104-11. doi: 10.1016/j.ygyno.2015.07.100. Epub 2015 Jul 20.

25.

GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.

Howitt BE, Emori MM, Drapkin R, Gaspar C, Barletta JA, Nucci MR, McCluggage WG, Oliva E, Hirsch MS.

Am J Surg Pathol. 2015 Oct;39(10):1411-9. doi: 10.1097/PAS.0000000000000471.

PMID:
26135559
26.

Editorial Commentary: Age-Old Questions: When to Start Antiretroviral Therapy and in Whom?

Walensky RP, Hirsch MS.

Clin Infect Dis. 2015 Oct 1;61(7):1196-8. doi: 10.1093/cid/civ467. Epub 2015 Jun 16. No abstract available.

PMID:
26082510
27.

Detecting metastatic prostate carcinoma in pelvic lymph nodes following neoadjuvant hormone therapy: the eyes have it!

Kehr E, Masry P, Lis R, Loda M, Taplin ME, Hirsch MS.

Histopathology. 2016 Jan;68(2):303-7. doi: 10.1111/his.12739. Epub 2015 Jul 14.

PMID:
26018610
28.

Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.

Aron M, Chang E, Herrera L, Hes O, Hirsch MS, Comperat E, Camparo P, Rao P, Picken M, Michal M, Montironi R, Tamboli P, Monzon F, Amin MB.

Am J Surg Pathol. 2015 Jul;39(7):873-88. doi: 10.1097/PAS.0000000000000446.

PMID:
25970682
29.

GATA3 expression in gestational trophoblastic tissues and tumours.

Mirkovic J, Elias K, Drapkin R, Barletta JA, Quade B, Hirsch MS.

Histopathology. 2015 Nov;67(5):636-44. doi: 10.1111/his.12681. Epub 2015 May 12.

PMID:
25753145
30.

HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.

Conner JR, Hirsch MS, Jo VY.

Cancer Cytopathol. 2015 May;123(5):298-305. doi: 10.1002/cncy.21530. Epub 2015 Mar 4.

31.

Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.

Fennessy FM, Fedorov A, Penzkofer T, Kim KW, Hirsch MS, Vangel MG, Masry P, Flood TA, Chang MC, Tempany CM, Mulkern RV, Gupta SN.

Magn Reson Imaging. 2015 Sep;33(7):886-94. doi: 10.1016/j.mri.2015.02.008. Epub 2015 Feb 14.

32.

The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI.

Fedorov A, Penzkofer T, Hirsch MS, Flood TA, Vangel MG, Masry P, Tempany CM, Mulkern RV, Fennessy FM.

Acad Radiol. 2015 May;22(5):548-55. doi: 10.1016/j.acra.2014.12.022. Epub 2015 Feb 13.

33.

PD-L1 expression in nonclear-cell renal cell carcinoma.

Choueiri TK, Fay AP, Gray KP, Callea M, Ho TH, Albiges L, Bellmunt J, Song J, Carvo I, Lampron M, Stanton ML, Hodi FS, McDermott DF, Atkins MB, Freeman GJ, Hirsch MS, Signoretti S.

Ann Oncol. 2014 Nov;25(11):2178-84. doi: 10.1093/annonc/mdu445. Epub 2014 Sep 5.

34.

Immunohistochemical staining for BRAF V600E supports the diagnosis of metanephric adenoma.

Pinto A, Signoretti S, Hirsch MS, Barletta JA.

Histopathology. 2015 May;66(6):901-4. doi: 10.1111/his.12509. Epub 2015 Jan 23. No abstract available.

PMID:
25130952
35.

Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.

Williamson SR, Eble JN, Amin MB, Gupta NS, Smith SC, Sholl LM, Montironi R, Hirsch MS, Hornick JL.

Mod Pathol. 2015 Jan;28(1):80-94. doi: 10.1038/modpathol.2014.86. Epub 2014 Jul 18.

36.

β-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers.

Myers A, Barry WT, Hirsch MS, Matulonis U, Lee L.

Gynecol Oncol. 2014 Aug;134(2):426-7. doi: 10.1016/j.ygyno.2014.06.010. Epub 2014 Jun 18. No abstract available.

PMID:
24952365
37.

Teratoma with malignant transformation: report of three cases and review of the literature.

Cabral FC, Krajewski KM, Rosenthal MH, Hirsch MS, Howard SA.

Clin Imaging. 2014 Sep-Oct;38(5):589-93. doi: 10.1016/j.clinimag.2014.04.011. Epub 2014 Apr 28. Review.

PMID:
24908364
38.

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.

Guancial EA, Werner L, Bellmunt J, Bamias A, Choueiri TK, Ross R, Schutz FA, Park RS, O'Brien RJ, Hirsch MS, Barletta JA, Berman DM, Lis R, Loda M, Stack EC, Garraway LA, Riester M, Michor F, Kantoff PW, Rosenberg JE.

Cancer Med. 2014 Aug;3(4):835-44. doi: 10.1002/cam4.262. Epub 2014 May 21.

39.

Reply to Korch.

Hooper DC, Hirsch MS.

J Infect Dis. 2014 Nov 1;210(9):1517-8. doi: 10.1093/infdis/jiu270. Epub 2014 May 7. No abstract available.

PMID:
24808388
40.

Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity.

Amin MB, Smith SC, Agaimy A, Argani P, Compérat EM, Delahunt B, Epstein JI, Eble JN, Grignon DJ, Hartmann A, Hes O, Hirsch MS, Jimenez RE, Kunju LP, Martignoni G, McKenney JK, Moch H, Montironi R, Paner GP, Rao P, Srigley JR, Tickoo SK, Reuter VE.

Am J Surg Pathol. 2014 Jul;38(7):871-4. doi: 10.1097/PAS.0000000000000222. No abstract available.

41.

Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy.

Rose BS, Chen MH, Zhang D, Hirsch MS, Richie JP, Chang SL, Hegde JV, Loffredo MJ, D'Amico AV.

Clin Genitourin Cancer. 2014 Oct;12(5):e173-9. doi: 10.1016/j.clgc.2014.03.008. Epub 2014 Mar 28.

PMID:
24787967
42.

The effect of differing Gleason scores at biopsy on the odds of upgrading and the risk of death from prostate cancer.

Phillips JG, Aizer AA, Chen MH, Zhang D, Hirsch MS, Richie JP, Tempany CM, Williams S, Hegde JV, Loffredo MJ, D'Amico AV.

Clin Genitourin Cancer. 2014 Oct;12(5):e181-7. doi: 10.1016/j.clgc.2014.02.008. Epub 2014 Mar 3.

43.

Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases.

Schoolmeester JK, Howitt BE, Hirsch MS, Dal Cin P, Quade BJ, Nucci MR.

Am J Surg Pathol. 2014 Feb;38(2):176-88. doi: 10.1097/PAS.0000000000000133.

PMID:
24418852
44.

Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.

Karst AM, Jones PM, Vena N, Ligon AH, Liu JF, Hirsch MS, Etemadmoghadam D, Bowtell DD, Drapkin R.

Cancer Res. 2014 Feb 15;74(4):1141-52. doi: 10.1158/0008-5472.CAN-13-2247. Epub 2013 Dec 23.

45.

Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms.

Elias KM, Labidi-Galy SI, Vitonis AF, Hornick JL, Doyle LA, Hirsch MS, Cramer DW, Drapkin R.

Gynecol Oncol. 2014 Feb;132(2):328-33. doi: 10.1016/j.ygyno.2013.12.011. Epub 2013 Dec 14.

46.

Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.

Perets R, Wyant GA, Muto KW, Bijron JG, Poole BB, Chin KT, Chen JY, Ohman AW, Stepule CD, Kwak S, Karst AM, Hirsch MS, Setlur SR, Crum CP, Dinulescu DM, Drapkin R.

Cancer Cell. 2013 Dec 9;24(6):751-65. doi: 10.1016/j.ccr.2013.10.013.

47.

Models of care and NCCN guideline adherence in very-low-risk prostate cancer.

Aizer AA, Paly JJ, Zietman AL, Nguyen PL, Beard CJ, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA.

J Natl Compr Canc Netw. 2013 Nov;11(11):1364-72.

PMID:
24225970
48.

Novel clostridium botulinum toxin and dual use research of concern issues.

Hooper DC, Hirsch MS.

J Infect Dis. 2014 Jan 15;209(2):167. doi: 10.1093/infdis/jit528. Epub 2013 Oct 7. No abstract available.

49.

FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis.

Levanon K, Sapoznik S, Bahar-Shany K, Brand H, Shapira-Frommer R, Korach J, Hirsch MS, Roh MH, Miron A, Liu JF, Vena N, Ligon AH, Fotheringham S, Bailey D, Flavin RJ, Birrer MJ, Drapkin RI.

Oncogene. 2014 Aug 28;33(35):4424-32. doi: 10.1038/onc.2013.394. Epub 2013 Sep 30.

50.

Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.

Wright AA, Howitt BE, Myers AP, Dahlberg SE, Palescandolo E, Van Hummelen P, MacConaill LE, Shoni M, Wagle N, Jones RT, Quick CM, Laury A, Katz IT, Hahn WC, Matulonis UA, Hirsch MS.

Cancer. 2013 Nov 1;119(21):3776-83. doi: 10.1002/cncr.28288. Epub 2013 Aug 23.

Supplemental Content

Loading ...
Support Center